New research suggests that microdosing a popular psychedelic may provide relief for people struggling with major depressive ...

To provide some solid data, the authors of the new study gave LSD to a group of patients in New Zealand, and instructed them ...

MindBio Therapeutics Corp. announced the results of its Phase 2B clinical trial investigating the effects of microdosed LSD on Major Depressive Disorder (MDD). The trial found that microdosed LSD did ...

Although a large volume of anecdotal reports have been published over the last few years affirming the value of LSD microdosing, there has been very little scientific or empirical study on this ...

While dosing is the most significant determinant, other psychological and pharmacological factors also play a critical role. A positive mood before drug intake was strongly linked to elevated ratings ...

Reported benefits of microdosing may be due to the placebo effect. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. People who microdose, or take ...

Just weeks after a double-blind, placebo-controlled trial found psilocybin microdosing to be no different to placebo, another study has been published that found LSD microdoses have no effect on mood ...

NEW YORK, Nov. 16, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD; NEO: MMED; DE: MMQ; the "Company"), a leading biotech company developing psychedelic-inspired therapies, is pleased ...

A new study published in the journal Neuropsychopharmacology provided results from one of the first modern clinical investigations of its kind to compare the effects of psychedelic drugs lysergic acid ...